红日药业(300026.SZ)：姚小青拟减持不超过1.5624%股份

Summary of Key Points Core Viewpoint - Hongri Pharmaceutical (300026.SZ) announced plans for share reductions by major shareholders and senior management, indicating potential changes in ownership structure and market sentiment [1] Group 1: Shareholder Reductions - Shareholder Yao Xiaoqing, holding 300,415,428 shares (10.0000% of total shares), plans to reduce holdings by up to 46,936,332 shares (1.5624% of total shares) within three months after a 15-trading-day notice period [1] - Senior management member Chen Ruiqiang, holding 677,900 shares (0.0226% of total shares), intends to sell up to 169,000 shares (0.0056% of total shares) through centralized bidding within the same timeframe [1] - Another senior management member, Zhang Kun, holding 931,750 shares (0.0310% of total shares), plans to reduce holdings by up to 232,000 shares (0.0077% of total shares) via centralized bidding within the specified period [1]